These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2826821)

  • 21. Antisense oligonucleotide inhibition of encephalomyocarditis virus RNA translation.
    Sankar S; Cheah KC; Porter AG
    Eur J Biochem; 1989 Sep; 184(1):39-45. PubMed ID: 2476310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice.
    Hirasawa K; Ogiso Y; Takeda M; Lee MJ; Itagaki S; Doi K
    Lab Anim Sci; 1995 Dec; 45(6):652-6. PubMed ID: 8746525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of viral RNA in the spinal cord of DBA/2 mice developing biphasic paralysis following infection with the D variant of encephalomyocarditis virus (EMC-D).
    Takeda M; Miura R; Shiota K; Hirasawa K; Lee MJ; Itagaki SI; Doi K
    Int J Exp Pathol; 1995 Dec; 76(6):441-7. PubMed ID: 8652364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nucleotide sequence of the 3'-terminus of encephalomyocarditis virus RNA].
    Petrov NA; Chizhikov VE; Blinov VM; Karginov VA; Mikriukov NN
    Bioorg Khim; 1984 Feb; 10(2):274-9. PubMed ID: 6091680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.
    Jordan GW; Cohen SH
    Rev Infect Dis; 1987; 9(5):917-24. PubMed ID: 2825321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The nucleotide sequence of the 3'-terminal region of encephalomyocarditis virus RNA].
    Grachev SA; Pletnev AG; Vasilenko SK; Petrov NA; Chizhikov VE
    Bioorg Khim; 1983 Jul; 9(7):986-9. PubMed ID: 6091696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Size and location of poly (A) in encephalomyocarditis virus RNA.
    Frisby D; Smith J; Jeffers V; Porter A
    Nucleic Acids Res; 1976 Oct; 3(10):2789-810. PubMed ID: 186764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of sequence and pathogenic properties of two variants of encephalomyocarditis virus differing in a single amino acid in VP1.
    Nelsen-Salz B; Zimmermann A; Wickert S; Arnold G; Botta A; Eggers HJ; Kruppenbacher JP
    Virus Res; 1996 Apr; 41(2):109-22. PubMed ID: 8738170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle.
    Jongen PJ; Zoll GJ; Beaumont M; Melchers WJ; van de Putte LB; Galama JM
    Ann Rheum Dis; 1993 Aug; 52(8):575-8. PubMed ID: 8215618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of viral RNA by electron microscopic in situ hybridization (ISH-EM) in the germinal epithelium of mice infected with encephalomyocarditis (EMC) virus.
    Ueno A; Takeda M; Hirasawa K; Itagaki S; Doi K
    Exp Anim; 1997 Jan; 46(1):79-81. PubMed ID: 9027476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region.
    Palmenberg AC; Kirby EM; Janda MR; Drake NL; Duke GM; Potratz KF; Collett MS
    Nucleic Acids Res; 1984 Mar; 12(6):2969-85. PubMed ID: 6324136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cDNA hybridization on translation of encephalomyocarditis virus RNA.
    Shih DS; Park IW; Evans CL; Jaynes JM; Palmenberg AC
    J Virol; 1987 Jun; 61(6):2033-7. PubMed ID: 3033330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point mutations which drastically affect the polymerization activity of encephalomyocarditis virus RNA-dependent RNA polymerase correspond to the active site of Escherichia coli DNA polymerase I.
    Sankar S; Porter AG
    J Biol Chem; 1992 May; 267(14):10168-76. PubMed ID: 1315753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The susceptibility of pregnant mice to encephalomyocarditis (EMC) virus infection on different days of gestation.
    Nakayama Y; Su W; Katayama K; Nakayama H; Doi K
    Exp Anim; 2004 Apr; 53(2):165-9. PubMed ID: 15153681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental encephalomyocarditis virus infection in pregnant mice.
    Nakayama Y; Su W; Ohguchi A; Nakayama H; Doi K
    Exp Mol Pathol; 2004 Oct; 77(2):133-7. PubMed ID: 15351236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus.
    Jun HS; Kang Y; Notkins AL; Yoon JW
    J Virol; 1997 Dec; 71(12):9782-5. PubMed ID: 9371645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of interferon in the protection of ICR Swiss male mice by the nondiabetogenic variant of encephalomyocarditis virus against virus-induced diabetes mellitus.
    Kaptur PE; Thomas DC; Giron DJ
    J Interferon Res; 1989 Dec; 9(6):671-8. PubMed ID: 2481700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of T cells, B cells, antibodies and macrophages against encephalomyocarditis (EMC)-D virus-induced diabetes in mice.
    Kounoue E; Izumi K; Ogawa S; Kondo S; Katsuta H; Akashi T; Niho Y; Harada M; Tamiya S; Kurisaki H; Nagafuchi S
    Arch Virol; 2008; 153(7):1223-31. PubMed ID: 18500429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective interfering particles of encephalomyocarditis virus.
    Radloff RJ; Young SA
    J Gen Virol; 1983 Jul; 64 (Pt 7)():1637-41. PubMed ID: 6306154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and production of monoclonal antibodies against a discriminating protein molecule between B and D variants of encephalomyocarditis virus.
    Qureshi MA; Yoon JW; Kwon BS
    Dev Comp Immunol; 1989; 13(3):263-71. PubMed ID: 2551748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.